Context Therapeutics Inc CNTX

‎$‎2.720.07(2.64%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Price Target

6.00

Based on analysts who covered CNTX

Invest in Context Therapeutics Inc
Today

Create an eToro account to buy CNTX stock on a secure, user-friendly, multi-asset trading platform.

Context Therapeutics Inc CNTX

Buy CNTX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

EIFF.PA

Societe de la Tour Eiffel SA

Eastman Kodak Company

Alerion Clean Power S.p.A

‎€‎21.75

+6.36%

SBAC

SBA Communications Corporation

MAX

*Past performance is not an indication of future results

Jump to:

About CNTX >
How to Buy? >
Top Guides >

The Context Therapeutics Inc share price is stable this week.

The Context Therapeutics Inc price today is ‎$‎2.72, a ‎2.64‎% change in the last 24 hours and ‎0‎% in the past week. Context Therapeutics Inc price changed by ‎0‎% in the past year.

CNTX Key Metrics

Market Cap

Day’s Range

‎$‎2.55 - ‎$‎2.94

52W Range

‎$‎1.07 - ‎$‎3.61

Average Volume (3M)

Price-Earnings Ratio

Revenue

Dividend (Yield)

Prev Close

‎$‎2.72

EPS

Beta

How can I buy Context Therapeutics Inc stocks?

To purchase Context Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Context Therapeutics Inc (CNTX) page and place an order to buy Context Therapeutics Inc.

Buy CNTX

Looking for more information? Check out our guide on Academy.

What Is Context Therapeutics Inc?

Context Therapeutics Inc is a US-based clinical-stage biopharmaceutical company focused on developing innovative treatments for hormone-driven cancers. Its goal is to improve patient outcomes by targeting biological pathways linked to tumor growth and resistance.

Operating within the biotechnology sector, Context Therapeutics Inc is advancing novel therapies through preclinical research and human trials. The company targets key protein interactions that contribute to disease progression. Its pipeline aims to introduce effective and differentiated treatment options for patients with limited alternatives.

Monitor the CNTX share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

Martin A. Lehr, MA

Employees

Founded

2015

Philadelphia, Pennsylvania, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Context Therapeutics Inc
Today

Create an eToro account to buy CNTX stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Context Therapeutics Inc stock?

The current price of CNTX is ‎$‎2.72.

What is Context Therapeutics Inc’s stock future price target?

The average price target for Context Therapeutics Inc is ‎$‎6.00. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Context Therapeutics Inc?

Analysts offer forecasts for Context Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Context Therapeutics Inc?

The market capitalisation of Context Therapeutics Inc is (The data is unavailable right now)

Is Context Therapeutics Inc stock buy, sell or hold?

Based on 3 analysts offering recommendations for CNTX in the last 3 months, the overall consensus is .

Daily Movers

Explore the biggest stocks movers on the market.